Frankshtal Court Prepares for Vaccine Damage Trial: Date Set for February 20
Prepare yourself for some legally charged drama, folks! The Regional Court in Frankshtal has marked February 20, 2024 (9:00 a.m.) on their calendars for the verdict announcement in a hotly contested lawsuit. The lawsuit stems from allegations of health damage stemming from a COVID-19 vaccination.
The court spokesperson in Frankshtal shared that the verdict might contain a variety of orders, such as collecting evidence, supplying information, or imposing specific conditions. They went on to say that the woman residing in Rhineland-Palatinate is suing Mainz-based vaccine conglomerate Biontech for damage incurred following a second vaccination.
Specifically, the unsuspecting victim claimed that the medication resulted in a bilateral pulmonary artery embolism – a blockage affecting blood vessels in the lungs – which was challenging to pinpoint as the root cause. Due to the ambiguity, she attributed the tragic event to the vaccine injection.
The public hearing took place yesterday, and the request for exclusion of the public by the plaintiff was denied. Regrettably, no settlement was reached.
(Enrichment Data: It's important to note that legal battles over COVID-19 vaccines are not a rarity in Germany, with multiple cases dismissed based on alleged vaccine damage. In another instance, BioNTech and Pfizer are embroiled in patent dispute cases with competing manufacturers such as Moderna and CureVac.)
This lawsuit forms part of the broader debate surrounding COVID-19 vaccinations, public health, and vaccine manufacturers like Biontech. As our legal system wrestles with these issues, we remain committed to staying informed and engaged on these topics.
Reading Recommendations:
Source:
